Forte Biosciences (FBRX) Operating Expenses (2016 - 2026)
Forte Biosciences (FBRX) reported Operating Expenses of $24.6 million for Q2 2026, up 112.5% from $11.58 million a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Operating Expenses (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Forte Biosciences' Operating Expenses came in at $90 million, up 106.0% year-over-year; for FY2025, it was $70.66 million, up 93.0% from FY2024.
- Operating Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- By year, Operating Expenses came in at $36.6 million in FY2024 (+12.7%), $32.49 million in FY2023 (+133.8%), $13.9 million in FY2022 (-35.3%) and $21.49 million in FY2021 (-53.6%).
- The Q2 2026 figure ranks as the highest quarterly Operating Expenses since Q2 2020.
- Year over year, Operating Expenses has now increased in each of the last four quarters, with growth averaging 74.4% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was Q4 2025 (growth of 234.3%); the low point was Q3 2022 (a decline of 55.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $22.44 million (Q1 2026), $24.57 million (Q4 2025) and $18.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | 24.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.60 Mn |
| Mar 31, 2026 | 22.44 Mn |
| Dec 31, 2025 | 24.57 Mn |
| Sep 30, 2025 | 18.38 Mn |
| Jun 30, 2025 | 11.58 Mn |
| Mar 31, 2025 | 16.12 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 8.63 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 6.38 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 9.03 Mn |
| Mar 31, 2023 | 6.86 Mn |
| Dec 31, 2022 | 4.94 Mn |
| Sep 30, 2022 | 3.42 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 7.70 Mn |
API Access
Forte Biosciences Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();